Vice President Corporate Business Development (Cell ...

Vice President Corporate & Business Development (Cell Therapy)Immix Biopharma, Inc (NASDAQ:IMMX)Los Angeles, CA / HybridOur 3 Core Values IntelligenceIntegrityInitiativeWhat You'll Do • Establish and maintain strong relationships with pharmaceutical and biotech companies; identify potential strategic corporate development and business partners• Source, screen and track business opportunities that are aligned with corporate goals and objectives by interacting with biotech, and pharma counterparts• Lead information research and provide robust analytic and business evaluation support of corporate and business development opportunities, potential company strategies, and key business initiatives• Develop and present robust financial models and market analyses to value projects• Visible external liaison in the scientific and biotech communities to raise awareness of company's partnering objectives and capabilities• Attend strategic partnering and industry conferences related to therapeutic area of interest• Monitor and advise the Company's leadership on competitive intelligence and relevant developments in key indications and therapeutic areas of interestSkills and Experience We Look For • Bachelor's degree or higher in biology, finance or related field with 5-10 years' biopharma/pharmaceutical experience• Established track record of successful strategic transactions in the biopharmaceutical industry• Strong knowledge of biotechnology/pharmaceutical industry, drug discovery and development• Excellent verbal and written communication skills, strong relationship management skills and strategic thinking• Proven experience successfully supporting the scientific and business evaluation of technologies, assets, or companies in the biotechnology/pharmaceutical industry• Demonstrated understanding of pharmaceutical product lifecycle management including drug development, FDA regulations, and commercialization paths• Outstanding organizational, analytical, interpersonal and communication skills• Adaptability, flexibility, and willingness to work in a changing environment• Experience with financial analysis and/ or valuation of biopharmaceutical products and companies and advanced excel/modeling skills required• A collaborative nature with the knowledge and understanding of the role and importance of working cross-functionally• Self-starter, highly motivated, results-driven individual; ability to creatively solve problems• Process-minded with the ability to operate strategically and adapt when appropriate to execute on defined goals in a timely manner• Experience preparing and delivering presentations to senior management• Familiarity with biopharma / pharmaceutical portfolio strategy and competitive dynamicsRewards at ImmixCompensation commensurate with experience. Health insurance and 401k included.About Immix Biopharma, Inc.Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201. NXC-201 is being evaluated in the U.S. Phase 1b/2 trial NEXICART-2 (NCT06097832) as well as the ex-U.S. study NEXICART-1 (NCT04720313). NXC-201 has demonstrated no neurotoxicity of any kind in AL Amyloidosis and short duration of cytokine release syndrome (CRS), supporting expansion into select immune-mediated diseases. NXC-201 has been awarded Orphan Drug Designation (ODD) in AL Amyloidosis by the US FDA and in the EU by the EMA. Learn more at and .

Created: 2025-01-24